Second-look TURBT showed limited value in altering outcomes for high-grade Ta bladder cancer after complete resection.

TURBT was associated with persistent sexual dysfunction in men, pointing to the importance of incorporating sexual health into postoperative evaluation.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The multicenter ENVISION trial included 240 adults who had recurred after TURBT and who had multiple tumors, a solitary tumor > 3 cm, and/or a recurrence within 1 year of TURBT.

Carlsbad, California Tuesday, July 1, 2025, 16:00 Hrs [IST] ...

At the 3-month evaluation, the CR rate was 64.8% for those receiving TURBT, whereas the CR rate for the UGN-102 group was slightly lower at 63.6%. 2 Nevertheless, at the 12-month follow-up, 79.7% ...

Previous data from the phase 3 ATLAS trial showed that UGN-102 may also benefit patients regardless of whether they had TURBT. In that study, newly diagnosed patients who received UGN-102 had a ...

June brought genitourinary cancer updates, and CURE is sharing the latest in kidney cancer treatment, as well as FDA ...

"For decades, TURBT has been the standard approach for bladder cancer treatment. That’s why innovative treatments like ZUSDURI are essential, especially for those adult patients with recurrent ...